PAK1 and liver cancer: As for Hippo/YAP cascade, the activation of FAK-ILK-PAK1 signaling will suppress the Hippo/YAP pathway to inhibit its tumor-suppressor role thus promoting the liver cancer cells cytoskeletal modulation 169.